KS 341
Latest Information Update: 24 Mar 1995
At a glance
- Originator Sankyo
- Class Antihypertensives
- Mechanism of Action Purinergic P1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 06 Mar 1995 Discontinued-Preclinical for Hypertension in Japan (Unknown route)